The interaction of BMP-7 and ActRII implicates a new mode of receptor assembly

Trends in Biochemical Sciences

Volumn 28, Issue 10, 2003, Pages 518-521

  Sebald, Walter ^a   Mueller, Thomas D ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR 2; LIGAND; OSTEOGENIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA; ACTIVIN RECEPTOR TYPE II A; ACTIVIN RECEPTOR TYPE II-A; BONE MORPHOGENETIC PROTEIN;

CELL MEMBRANE; CRYSTAL STRUCTURE; DIFFUSION; LIGAND BINDING; MEMBRANE TRANSPORT; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; RECEPTOR AFFINITY; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; X RAY ANALYSIS; ANIMAL; BIOLOGICAL MODEL; KINETICS; METABOLISM; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE;

ACTIVIN RECEPTORS, TYPE II; ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL MEMBRANE; KINETICS; LIGANDS; MODELS, BIOLOGICAL; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; TRANSFORMING GROWTH FACTOR BETA;

EID: 0642285636     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2003.08.001     Document Type: Short Survey

References (20)

1. Schlessinger J. Signal transduction by allosteric receptor oligomerization. Trends Biochem. Sci. 13:1988;443-447.
2. Schlessinger J. Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell. 110:2002;669-672.
3. Bernat B., et al. Determination of the energetics governing the regulatory step in growth hormone-induced receptor homodimerization. Proc. Natl. Acad. Sci. U. S. A. 100:2003;952-957.
4. Krause C.D., et al. Seeing the light: preassembly and ligand-induced changes of the interferon γ receptor complex in cells. Mol. Cell. Proteomics. 1:2002;805-815.
5. Nohe A., et al. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J. Biol. Chem. 277:2002;5330-5338.
6. Ottemann K.M., et al. A piston model for transmembrane signaling of the aspartate receptor. Science. 285:1999;1751-1754.
7. Greenwald J., et al. The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Mol. Cell. 11:2003;605-617.
8. Hogan B.L. Bone morphogenetic proteins in development. Curr. Opin. Genet. Dev. 6:1996;432-438.
9. Massague J. TGF-β signal transduction. Annu. Rev. Biochem. 67:1998;753-791.
10. Souchelnytskyi S., et al. TGF-β signaling from a three-dimensional perspective: insight into selection of partners. Trends Cell Biol. 12:2002;304-307.
11. Kirsch T., et al. BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II. EMBO J. 19:2000;3314-3324.
12. Thompson T.B., et al. Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-β ligand:receptor interactions. EMBO J. 22:2003;1555-1566.
13. Hart P.J., et al. Crystal structure of the human TβR2 ectodomain-TGF-β3 complex. Nat. Struct. Biol. 9:2002;203-208.
14. Kirsch T., et al. Crystal structure of the BMP-2-BRIA ectodomain complex. Nat. Struct. Biol. 7:2000;492-496.
15. Wrana J.L., et al. Mechanism of activation of the TGF-β receptor. Nature. 370:1994;341-347.
16. riffith D.L., et al. Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor β superfamily. Proc. Natl. Acad. Sci. U. S. A. 93:1996;878-883.
17. Grasberger B., et al. Interaction between proteins localized in membranes. Proc. Natl. Acad. Sci. U. S. A. 83:1986;6258-6262.
18. Letzelter F., et al. The interleukin-4 site-2 epitope determining binding of the common receptor γ chain. Eur. J. Biochem. 257:1998;11-20.
19. Schomburg D., et al. Springer Handbook of Enzymes. 2nd edn:2002;Springer Verlag.
20. Livnah O., et al. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science. 283:1999;987-990.